IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Drug Development and Registration

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

0.74

h-Index

2022-2023

 5

Rank

2022-2023

 19643

SJR

2022-2023

 0.191

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Drug Development and Registration
Abbreviation Drug Dev. Regist.
Publication Type Journal
Subject Area, Categories, Scope Pharmaceutical Science (Q3); Drug Discovery (Q4)
h-index 5
Overall Rank/Ranking 19643
SCImago Journal Rank (SJR) 0.191
Impact Score 0.74
Publisher Center of Pharmaceutical Analytics
Country Russian Federation
ISSN 26585049, 23052066
Best Quartile Q3
Coverage History 2020-2022




About Drug Development and Registration


Drug Development and Registration is a journal covering the technologies/fields/categories related to Pharmaceutical Science (Q3); Drug Discovery (Q4). It is published by Center of Pharmaceutical Analytics. The overall rank of Drug Development and Registration is 19643. According to SCImago Journal Rank (SJR), this journal is ranked 0.191. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 5. The best quartile for this journal is Q3.

The ISSN of Drug Development and Registration journal is 26585049, 23052066. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Drug Development and Registration is cited by a total of 157 articles during the last 3 years (Preceding 2022).


Drug Development and Registration Impact IF 2022-2023


The Impact IF 2022 of Drug Development and Registration is 0.74, which is computed in 2023 as per its definition. Drug Development and Registration IF is decreased by a factor of 0.01 and approximate percentage change is -1.33% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Drug Development and Registration Impact IF 2023 Prediction


Impact IF 2022 of Drug Development and Registration is 0.74. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Drug Development and Registration. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 0.74
2021 0.75
2020 0.29
2019 0.00

Drug Development and Registration h-index


  Table Setting

Drug Development and Registration has an h-index of 5. It means 5 articles of this journal have more than 5 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Drug Development and Registration ISSN


The ISSN of Drug Development and Registration is 26585049, 23052066. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Drug Development and Registration Rank and SCImago Journal Rank (SJR)


The overall rank of Drug Development and Registration is 19643. According to SCImago Journal Rank (SJR), this journal is ranked 0.191. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Drug Development and Registration by Year


Year SJR
2023/2024 Coming Soon
2022 0.191
2021 0.156
2020
2019

Ranking of Drug Development and Registration by Year


Year Ranking
2023/2024 Coming Soon
2022 19643
2021 20792
2020 33154
2019 30753

Drug Development and Registration Publisher


Table Setting

Drug Development and Registration is published by Center of Pharmaceutical Analytics. It's publishing house is located in Russian Federation. Coverage history of this journal is as following: 2020-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Drug Development and Registration is Drug Dev. Regist.. This abbreviation ('Drug Dev. Regist.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Drug Development and Registration


If your research field is/are related to Pharmaceutical Science (Q3); Drug Discovery (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Drug Development and Registration?

Drug Development and Registration latest impact IF is 0.74. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 0.75 (2021) and 0.00 (2019), respectively, in the last 4 years. Moreover, its average IS is 0.45 in the previous 4 years.


What's the SCImago Journal Rank (SJR) of the Drug Development and Registration?

The Drug Development and Registration has an SJR (SCImago Journal Rank) of 0.191, according to the latest data. It is computed in the year 2023. In the past 4 years, this journal has recorded a range of SJR, with the highest being 0.191 in 2022 and the lowest being in 2020. Furthermore, the average SJR of the Drug Development and Registration over the previous 4-year period stands at 0.45.


What's the latest h-index of the Drug Development and Registration?

The latest h-index of the Drug Development and Registration is 5.


Who's the publisher of the Drug Development and Registration?

The Drug Development and Registration is published by the Center of Pharmaceutical Analytics, with its country of publication being the Russian Federation.


What's the current ranking of the Drug Development and Registration?

The Drug Development and Registration is currently ranked 19643 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 4 years, this journal has experienced varying rankings, reaching its highest position of 19643 in 2022 and its lowest position of 33154 in 2020.


What's the abbreviation or short name for the Drug Development and Registration?

The standard ISO4 abbreviation for the Drug Development and Registration is Drug Dev. Regist..


Is the "Drug Development and Registration" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Drug Development and Registration is classified as a journal that the Center of Pharmaceutical Analytics publishes.


What's the scope or major areas of the Drug Development and Registration?

The Drug Development and Registration encompasses the following areas:

  • Pharmaceutical Science
  • Drug Discovery

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Drug Development and Registration?

The Drug Development and Registration is assigned the following International Standard Serial Numbers (ISSN): 26585049, 23052066.


What's the best quartile of the Drug Development and Registration?

The best quartile for the Drug Development and Registration is Q3 (2022).


What's the coverage history of the Drug Development and Registration?

The Drug Development and Registration coverage history can be summarized as follows: 2020-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Mathematical Modelling and Analysis journal 11315 Vilnius Gediminas Technical University 27 1.75
Howard Journal of Communications journal 9564 Taylor and Francis Ltd. 36 1.66
Exploration Geophysics journal 16383 Taylor and Francis Ltd. 48 1.17
SPE International Formation Damage Control Symposium Proceedings conference and proceedings 21934 16 0.00
Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria journal 25905 National Association of Resident Doctors of Nigeria 25 0.00
Brazilian Symposium of Computer Graphic and Image Processing conference and proceedings 16004 32 0.00
Cardiovascular Journal of Africa journal 16569 Clinics Cardive Publishing (PTY)Ltd 39 0.66
Physica Status Solidi - Rapid Research Letters journal 6699 Wiley-VCH Verlag 76 2.77
Journal of Evolutionary Psychology journal 28897 Akademiai Kiado 0 0.00
American Journal of Immunology (discontinued) journal 19764 Science Publications 12 1.56

Check complete list




Year wise Impact Score (IS) of Drug Development and Registration

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.74
2021 0.75
2020 0.29
2019 0.00



Top Journals/Conferences in Pharmaceutical Science

Nano Today
Elsevier | Netherlands

Advanced Drug Delivery Reviews
Elsevier | Netherlands

Advanced healthcare materials
John Wiley and Sons Ltd | United Kingdom

Journal of Controlled Release
Elsevier | Netherlands

Bioengineering and Translational Medicine
John Wiley & Sons Inc. | United States

Apoptosis : an international journal on programmed cell death
Springer Netherlands | Netherlands

Journal of Nanobiotechnology
BioMed Central Ltd. | United Kingdom

Asian Journal of Pharmaceutical Sciences
Shenyang Pharmaceutical University | China

Journal of Pharmaceutical Analysis
Xi'an Jiaotong University | China

Bioconjugate Chemistry
American Chemical Society | United States

See All

Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Protein and Cell
Higher Education Press | China

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Molecular Therapy - Nucleic Acids
Cell Press | United States

Journal of Medicinal Chemistry
American Chemical Society | United States

Antibodies
MDPI AG | Switzerland

See All